Which has higher earnings & valuation, HIMS or HTFL?

Hims & Hers Health has higher revenue and earnings than Heartflow. Hims & Hers Health is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Hims & Hers Health $2.35B 3.07 $128.37M -$0.09 N/A Heartflow $176.03M 17.39 -$116.79M -$3.11 N/A

Which has stronger earnings and valuation, HTFL or PACS?

PACS Group has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 17.39 -$116.79M -$3.11 N/A PACS Group $5.29B 1.20 $191.54M $1.56 25.65

Is HTFL or PACS more profitable?

PACS Group has a net margin of 4.49% compared to Heartflow's net margin of -58.42%. PACS Group's return on equity of 26.47% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -58.42% N/A -20.02% PACS Group 4.49% 26.47% 4.36%

Which has preferable valuation & earnings, SHC or HTFL?

Sotera Health has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Sotera Health $1.16B 4.22 $77.94M $0.41 42.02 Heartflow $176.03M 17.39 -$116.79M -$3.11 N/A

Which has stronger earnings & valuation, HTFL or RDNT?

RadNet has higher revenue and earnings than Heartflow. RadNet is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Heartflow $176.03M 17.39 -$116.79M -$3.11 N/A RadNet $2.04B 2.29 -$18.65M -$0.18 N/A

Is HTFL or RDNT more profitable?

RadNet has a net margin of -0.66% compared to Heartflow's net margin of -58.42%. RadNet's return on equity of 2.77% beat Heartflow's return on equity. Company Net Margins Return on Equity Return on Assets Heartflow -58.42% N/A -20.02% RadNet -0.66% 2.77% 0.97%

Heartflow (HTFL) Competitors

$35.58 +0.67 (+1.91%)

As of 11:01 AM Eastern

Compare

HTFL vs. HIMS, PACS, CAI, SHC, and RDNT

Should you buy Heartflow stock or one of its competitors? MarketBeat compares Heartflow with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Heartflow include Hims & Hers Health (HIMS), PACS Group (PACS), Caris Life Sciences (CAI), Sotera Health (SHC), and RadNet (RDNT). These companies are all part of the "healthcare" industry.

How does Heartflow compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Heartflow (NASDAQ:HTFL) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

Hims & Hers Health has higher revenue and earnings than Heartflow. Hims & Hers Health is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	3.07	$128.37M	-$0.09	N/A
Heartflow	$176.03M	17.39	-$116.79M	-$3.11	N/A

In the previous week, Hims & Hers Health had 18 more articles in the media than Heartflow. MarketBeat recorded 18 mentions for Hims & Hers Health and 0 mentions for Heartflow. Hims & Hers Health's average media sentiment score of 0.80 beat Heartflow's score of 0.00 indicating that Hims & Hers Health is being referred to more favorably in the media.

Company	Overall Sentiment
Hims & Hers Health	Positive
Heartflow	Neutral

Hims & Hers Health presently has a consensus target price of $29.37, indicating a potential downside of 5.56%. Heartflow has a consensus target price of $37.00, indicating a potential upside of 4.26%. Given Heartflow's stronger consensus rating and higher possible upside, analysts clearly believe Heartflow is more favorable than Hims & Hers Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	2 Sell rating(s)	10 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.13
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Hims & Hers Health has a net margin of -0.56% compared to Heartflow's net margin of -58.42%. Hims & Hers Health's return on equity of 6.10% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	-0.56%	6.10%	1.52%
Heartflow	-58.42%	N/A	-20.02%

63.5% of Hims & Hers Health shares are held by institutional investors. 11.8% of Hims & Hers Health shares are held by company insiders. Comparatively, 7.7% of Heartflow shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Hims & Hers Health beats Heartflow on 10 of the 15 factors compared between the two stocks.

How does Heartflow compare to PACS Group?

Heartflow (NASDAQ:HTFL) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

PACS Group has a net margin of 4.49% compared to Heartflow's net margin of -58.42%. PACS Group's return on equity of 26.47% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
PACS Group	4.49%	26.47%	4.36%

PACS Group has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than PACS Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	17.39	-$116.79M	-$3.11	N/A
PACS Group	$5.29B	1.20	$191.54M	$1.56	25.65

Heartflow presently has a consensus target price of $37.00, suggesting a potential upside of 4.26%. PACS Group has a consensus target price of $48.00, suggesting a potential upside of 19.96%. Given PACS Group's stronger consensus rating and higher possible upside, analysts clearly believe PACS Group is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
PACS Group	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

In the previous week, PACS Group had 8 more articles in the media than Heartflow. MarketBeat recorded 8 mentions for PACS Group and 0 mentions for Heartflow. PACS Group's average media sentiment score of 0.44 beat Heartflow's score of 0.00 indicating that PACS Group is being referred to more favorably in the news media.

Company	Overall Sentiment
Heartflow	Neutral
PACS Group	Neutral

Summary

PACS Group beats Heartflow on 11 of the 13 factors compared between the two stocks.

How does Heartflow compare to Caris Life Sciences?

Caris Life Sciences (NASDAQ:CAI) and Heartflow (NASDAQ:HTFL) are both mid-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, profitability, earnings, media sentiment, dividends, analyst recommendations and institutional ownership.

Caris Life Sciences presently has a consensus price target of $27.56, indicating a potential upside of 39.73%. Heartflow has a consensus price target of $37.00, indicating a potential upside of 4.26%. Given Caris Life Sciences' higher probable upside, research analysts plainly believe Caris Life Sciences is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Caris Life Sciences	1 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.45
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Caris Life Sciences has a net margin of 3.75% compared to Heartflow's net margin of -58.42%. Caris Life Sciences' return on equity of 98.28% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Caris Life Sciences	3.75%	98.28%	48.87%
Heartflow	-58.42%	N/A	-20.02%

Caris Life Sciences has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Caris Life Sciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Caris Life Sciences	$812.03M	6.86	-$68.09M	-$7.61	N/A
Heartflow	$176.03M	17.39	-$116.79M	-$3.11	N/A

In the previous week, Caris Life Sciences had 1 more articles in the media than Heartflow. MarketBeat recorded 1 mentions for Caris Life Sciences and 0 mentions for Heartflow. Caris Life Sciences' average media sentiment score of 0.95 beat Heartflow's score of 0.00 indicating that Caris Life Sciences is being referred to more favorably in the media.

Company	Overall Sentiment
Caris Life Sciences	Positive
Heartflow	Neutral

Summary

Caris Life Sciences beats Heartflow on 9 of the 12 factors compared between the two stocks.

How does Heartflow compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and Heartflow (NASDAQ:HTFL) are both mid-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

In the previous week, Sotera Health's average media sentiment score of 0.00 equaled Heartflow'saverage media sentiment score.

Company	Overall Sentiment
Sotera Health	Neutral
Heartflow	Neutral

Sotera Health has higher revenue and earnings than Heartflow. Heartflow is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	4.22	$77.94M	$0.41	42.02
Heartflow	$176.03M	17.39	-$116.79M	-$3.11	N/A

Sotera Health presently has a consensus price target of $20.25, suggesting a potential upside of 17.53%. Heartflow has a consensus price target of $37.00, suggesting a potential upside of 4.26%. Given Sotera Health's stronger consensus rating and higher probable upside, equities research analysts plainly believe Sotera Health is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.73
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56

Sotera Health has a net margin of 9.91% compared to Heartflow's net margin of -58.42%. Sotera Health's return on equity of 39.73% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
Heartflow	-58.42%	N/A	-20.02%

91.0% of Sotera Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 7.7% of Heartflow shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Sotera Health beats Heartflow on 12 of the 13 factors compared between the two stocks.

How does Heartflow compare to RadNet?

Heartflow (NASDAQ:HTFL) and RadNet (NASDAQ:RDNT) are both mid-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

RadNet has higher revenue and earnings than Heartflow. RadNet is trading at a lower price-to-earnings ratio than Heartflow, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heartflow	$176.03M	17.39	-$116.79M	-$3.11	N/A
RadNet	$2.04B	2.29	-$18.65M	-$0.18	N/A

77.9% of RadNet shares are owned by institutional investors. 7.7% of Heartflow shares are owned by insiders. Comparatively, 5.6% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

RadNet has a net margin of -0.66% compared to Heartflow's net margin of -58.42%. RadNet's return on equity of 2.77% beat Heartflow's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Heartflow	-58.42%	N/A	-20.02%
RadNet	-0.66%	2.77%	0.97%

Heartflow presently has a consensus target price of $37.00, indicating a potential upside of 4.26%. RadNet has a consensus target price of $87.43, indicating a potential upside of 46.99%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Heartflow.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heartflow	1 Sell rating(s)	2 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.56
RadNet	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	2 Strong Buy rating(s)	2.90

In the previous week, RadNet had 10 more articles in the media than Heartflow. MarketBeat recorded 10 mentions for RadNet and 0 mentions for Heartflow. RadNet's average media sentiment score of 0.05 beat Heartflow's score of 0.00 indicating that RadNet is being referred to more favorably in the news media.

Company	Overall Sentiment
Heartflow	Neutral
RadNet	Neutral

Summary

RadNet beats Heartflow on 12 of the 15 factors compared between the two stocks.

Get Heartflow News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTFL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HTFL vs. The Competition

Export

Metric	Heartflow	Health Information Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$3.07B	$356.50M	$6.65B	$12.12B
Dividend Yield	N/A	5.60%	2.68%	5.88%
P/E Ratio	-11.44	251.07	25.28	23.96
Price / Sales	17.39	131.53	539.96	107.19
Price / Cash	N/A	47.14	45.29	53.76
Price / Book	10.05	7.35	10.83	6.40
Net Income	-$116.79M	-$22.78M	$3.56B	$337.03M
7 Day Performance	5.49%	-0.19%	1.13%	-0.86%
1 Month Performance	20.34%	1.44%	0.96%	0.69%
1 Year Performance	N/A	-10.04%	30.77%	29.23%

Heartflow Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HTFL Heartflow	1.7589 of 5 stars	$35.49 +1.7%	$37.00 +4.3%	N/A	$3.07B	$176.03M	N/A	699
HIMS Hims & Hers Health	3.1369 of 5 stars	$28.76 +3.5%	$28.70 -0.2%	-24.1%	$6.66B	$2.37B	N/A	2,442	Insider Trade Gap Down
PACS PACS Group	4.0411 of 5 stars	$34.83 +1.5%	$48.00 +37.8%	+205.5%	$5.51B	$5.43B	22.33	47,455	Insider Trade
CAI Caris Life Sciences	4.4871 of 5 stars	$18.00 +4.9%	$27.56 +53.1%	N/A	$5.09B	$812.03M	N/A	1,846
SHC Sotera Health	3.4306 of 5 stars	$16.39 +0.7%	$20.29 +23.8%	+48.5%	$4.67B	$1.19B	39.98	3,000	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:HTFL) was last updated on 6/25/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Heartflow (HTFL) Competitors

HTFL vs. HIMS, PACS, CAI, SHC, and RDNT

How does Heartflow compare to Hims & Hers Health?

Summary

How does Heartflow compare to PACS Group?

Summary

How does Heartflow compare to Caris Life Sciences?

Summary

How does Heartflow compare to Sotera Health?

Summary

How does Heartflow compare to RadNet?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HTFL vs. The Competition

Heartflow Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Heartflow (HTFL) Competitors

HTFL vs. HIMS, PACS, CAI, SHC, and RDNT

How does Heartflow compare to Hims & Hers Health?

Which has higher earnings & valuation, HIMS or HTFL?

Does the media favor HIMS or HTFL?

Do analysts recommend HIMS or HTFL?

Is HIMS or HTFL more profitable?

Do insiders & institutionals have more ownership in HIMS or HTFL?

Summary

How does Heartflow compare to PACS Group?

Is HTFL or PACS more profitable?

Which has stronger earnings and valuation, HTFL or PACS?

Do analysts prefer HTFL or PACS?

Does the media refer more to HTFL or PACS?

Summary

How does Heartflow compare to Caris Life Sciences?

Do analysts prefer CAI or HTFL?

Is CAI or HTFL more profitable?

Which has higher valuation & earnings, CAI or HTFL?

Does the media prefer CAI or HTFL?

Summary

How does Heartflow compare to Sotera Health?

Does the media prefer SHC or HTFL?

Which has preferable valuation & earnings, SHC or HTFL?

Do analysts rate SHC or HTFL?

Is SHC or HTFL more profitable?

Do insiders and institutionals hold more shares of SHC or HTFL?

Summary

How does Heartflow compare to RadNet?

Which has stronger earnings & valuation, HTFL or RDNT?

Do institutionals and insiders have more ownership in HTFL or RDNT?

Is HTFL or RDNT more profitable?

Do analysts recommend HTFL or RDNT?

Does the media prefer HTFL or RDNT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HTFL vs. The Competition

Heartflow Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools